| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1171 | 2016 |
| Characterization of the gut microbiome using 16S or shotgun metagenomics J Jovel, J Patterson, W Wang, N Hotte, S O'Keefe, T Mitchel, T Perry, ... Frontiers in microbiology 7, 459, 2016 | 961 | 2016 |
| Association of diabetes mellitus and chronic hepatitis C virus infection AL Mason, JY Lau, N Hoang, KP Qian, GJ Alexander, L Xu, L Guo, ... Hepatology 29 (2), 328-333, 1999 | 956 | 1999 |
| The human gut microbiome in health and disease J Jovel, LA Dieleman, D Kao, AL Mason, E Wine Metagenomics, 197-213, 2018 | 852 | 2018 |
| The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis Z Li, LB Agellon, TM Allen, M Umeda, L Jewell, A Mason, DE Vance Cell metabolism 3 (5), 321-331, 2006 | 770 | 2006 |
| Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants GM Hirschfield, X Liu, C Xu, Y Lu, G Xie, Y Lu, X Gu, EJ Walker, K Jing, ... New England Journal of Medicine 360 (24), 2544-2555, 2009 | 727 | 2009 |
| Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid GM Hirschfield, A Mason, V Luketic, K Lindor, SC Gordon, M Mayo, ... Gastroenterology 148 (4), 751-761. e8, 2015 | 700 | 2015 |
| Effect of oral capsule–vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial D Kao, B Roach, M Silva, P Beck, K Rioux, GG Kaplan, HJ Chang, ... Jama 318 (20), 1985-1993, 2017 | 666 | 2017 |
| GP73, a novel Golgi-localized protein upregulated by viral infection RD Kladney, GA Bulla, L Guo, AL Mason, AE Tollefson, DJ Simon, ... Gene 249 (1-2), 53-65, 2000 | 559 | 2000 |
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 545 | 2014 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 509 | 2017 |
| Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C RH Wiesner, M Sorrell, F Villamil Liver Transplantation 9 (11), S1-S9, 2003 | 501 | 2003 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 476 | 2010 |
| Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ... Gastroenterology 149 (7), 1804-1812. e4, 2015 | 468 | 2015 |
| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ... Nature genetics 45 (6), 670-675, 2013 | 446 | 2013 |
| Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? S Nair, A Mason, J Eason, G Loss, RP Perrillo Hepatology 36 (1), 150-155, 2002 | 437 | 2002 |
| Sirolimus‐based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma NM Kneteman, J Oberholzer, M Al Saghier, GA Meeberg, M Blitz, MM Ma, ... Liver Transplantation 10 (10), 1301-1311, 2004 | 342 | 2004 |
| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 325 | 2015 |
| A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis KV Kowdley, V Luketic, R Chapman, GM Hirschfield, R Poupon, ... Hepatology 67 (5), 1890-1902, 2018 | 295 | 2018 |
| Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen AL Mason, L Xu, L Guo, M Kuhns, RP Perrillo Hepatology 27 (6), 1736-1742, 1998 | 287 | 1998 |
Gideon HirschfieldUniversity of TorontoVerified email at uhn.ca